University of Virginia opens center for ablation research

The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute. It is designed to become a leading center for translational research and patient care in this new and rapidly evolving field, said provost Dr. Tim Garson on dedication day, Sept 14.

The UVA center will offer uterine fibroid therapy, the first application of the focused ultrasound technology to receive FDA approval. It will also host clinical trials on uterine fibroids and fertility; Parkinson’s disease and epilepsy; liver, brain, breast, and prostate tumors; and pain control from bone tumors. The state of Virginia and the Focused Ultrasound Surgery Foundation covered $7.1 million of the $8 million cost of establishing the institute. Other contributors included GE Healthcare and InSightec, developer of the first FDA-approved MR-guided focused ultrasound ablation system.